Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony–Stimulating Factor Chemotherapy for Stage II Breast Cancer
Conclusion:
Twenty-five-year follow-up for this prospective randomized trial confirms the equivalency of preoperative versus postoperative chemotherapy with fluorouracil, leucovorin calcium, doxorubicin, and cyclophosphamides/granulocyte colony–stimulating factor for stage II breast cancer for both RFS and OS.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Breast Source Type: research
More News: Breast Cancer | Calcium | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Congestive Heart Failure | Heart | Heart Failure | Study | Toxicology | Women